Cite
HARVARD Citation
Park, J. et al. (2022). ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics. Journal for immunotherapy of cancer. 10 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Park, J. et al. (2022). ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics. Journal for immunotherapy of cancer. 10 (7), p. . [Online].